A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)

Clinical trial NCT00439803 · COMPLETED

Trial details

NCT number: NCT00439803
Sponsor: AlphaVax, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cytomegalovirus Infections

Start date: 2007-04-01
Primary completion: 2008-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.